ReviewGastroenterology & hepatology2009
Adverse Risks Associated With Proton Pump Inhibitors: A Systematic Review.
Review in Gastroenterology & hepatology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 36 citations in OpenAlex.
- Article
- Osseous implications of proton pump inhibitor therapy: An umbrella review.Bone reports · 2024Review
- Proton pump inhibitor prescribing patterns and utilization: A retrospective chart review analysis.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023Article
- Reducing Unnecessary Acid Suppression Use in Hospitalized Patients: A Description of Targeted Strategies Implemented Across a Large Health System.HCA healthcare journal of medicine · 2023Article
- Risk of bias in non-randomized observational studies assessing the relationship between proton-pump inhibitors and adverse kidney outcomes: a systematic review.Therapeutic advances in gastroenterology · 2022Review
- Associations of atrophic gastritis and proton-pump inhibitor drug use with vitamin B-12 status, and the impact of fortified foods, in older adults.The American journal of clinical nutrition · 2021Article
- Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer.Oxidative medicine and cellular longevity · 2020Review
- Article
- Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study.BMJ (Clinical research ed.) · 2016Article
- Review of Proton Pump Inhibitor Overuse in the US Veteran Population.The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2015Article
- Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later.Surgical endoscopy · 2014Article
- Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications.Therapeutic advances in drug safety · 2013Article
- Stretta Radiofrequency Treatment for GERD: A Safe and Effective Modality.Gastroenterology research and practice · 2013Review
- Overutilization of proton-pump inhibitors: what the clinician needs to know.Therapeutic advances in gastroenterology · 2012Article
- Impact of multi-approach strategy on acid suppressive medication use in a teaching hospital in Qatar.International journal of clinical pharmacy · 2011Article
- The value of branded proton pump inhibitors: formulary considerations.P & T : a peer-reviewed journal for formulary management · 2011Article
- Issues Related to BID Dosing of PPIs.Gastroenterology & hepatology · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Proton pump inhibitors (PPIs) are among the most commonly utilized agents for treatment of symptomatic disorders of the upper gastrointestinal tract, accounting for a significant proportion of sales of both over-the-counter and prescription formulations. A systematic review of the literature was conducted via MEDLINE to evaluate the most rigorous studies linking the potential risk of PPI therapy with adverse events. Emerging data illustrate the potential risks associated with both short-and long-term PPI therapy, including
Indexed as
Identifiers
37967443PMC2886361W1521431686What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.